No emergence of resistance mutations in COVID-19 patients receiving nirmatrelvir/ritonavir. Palomino-Cabrera R, Tejerina F, Molero-Salinas A, Veintimilla C, et al. J Med Virol 2024;96:e29337.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Palomino-Cabrera R, Tejerina F, Molero-Salinas A, Veintimilla C, et al. No emergence of resistance mutations in COVID-19 patients receiving nirmatrelvir/ritonavir. J Med Virol 2024;96:e29337.
PMID: 38149407